# Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

> **NCT00066456** · PHASE1 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 13 (actual)

## Conditions studied

- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Carcinoma
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer

## Interventions

- **RADIATION:** 3-Dimensional Conformal Radiation Therapy
- **DRUG:** Chemosensitization/Potentiation Therapy
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT00066456
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2010-07
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2016-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00066456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00066456, "Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00066456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*